Clinical Trial Update: Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on an oral DHEA (dehydroepiandrosterone) study for previously unexplained infertility in Phase 2/Phase 3, which has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Insufficiency
• Unexplained Infertility

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Center for Human Reproduction | Conditions: Primary Ovarian Insufficiency, Unexplained Infertility | Phase 2, Phase 3 | Status: TERMINATED